Patki A, Shelgaonkar V
Indian J Anaesth. 2010; 54(5):448-52.
PMID: 21189884
PMC: 2991656.
DOI: 10.4103/0019-5049.71045.
Mitra S, Khandelwal P
Indian J Anaesth. 2010; 53(5):592-607.
PMID: 20640110
PMC: 2900092.
Armstrong J, Wenby R, Meiselman H, Fisher T
Biophys J. 2004; 87(6):4259-70.
PMID: 15361408
PMC: 1304934.
DOI: 10.1529/biophysj.104.047746.
Kohler H, Zschiedrich H, Linfante A, Appel F, Pitz H, CLASEN R
Klin Wochenschr. 1982; 60(6):293-301.
PMID: 6176754
DOI: 10.1007/BF01716806.
LAWSON L
Postgrad Med J. 1967; 43(498):263-7.
PMID: 6042386
PMC: 2466287.
DOI: 10.1136/pgmj.43.498.263.
Experimental arterial thrombus prevention and renal function in sheep after infusion with low molecular weight dextran and dextran 70,000.
Hunt P, Reeve T
Ann Surg. 1967; 166(1):51-8.
PMID: 6028842
PMC: 1477355.
DOI: 10.1097/00000658-196707000-00006.
[Studies on the problem of the modification of carbohydrate metabolism by dextran infusions. II].
HIERHOLZER G, Rehn J, Gatos M
Langenbecks Arch Chir. 1968; 321(4):349-58.
PMID: 5725959
DOI: 10.1007/BF01442316.
[Comparative functional and light microscopic studies on the renal effect of extreme blood dilution using Rheomacrodex, Haemaccel or tutofusin].
HOLSCHER B
Langenbecks Arch Chir. 1968; 320(2):100-10.
PMID: 5670146
DOI: 10.1007/BF01439164.
[Kidney function following infusion of dextran and gelatine preparations without and with addition of THAM in experimental hemorrhagic shock].
HALLWACHS O, Lutz H
Langenbecks Arch Chir. 1967; 318(1):14-23.
PMID: 5584092
DOI: 10.1007/BF01439531.
Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroxyethyl starch 200/0.5.
Kroemer H, Haass A, Muller K, Jager H, Wagner E, HEIMBURG P
Eur J Clin Pharmacol. 1987; 31(6):705-10.
PMID: 2435558
DOI: 10.1007/BF00541299.
Clinical pharmacokinetic considerations in the use of plasma expanders.
Klotz U, Kroemer H
Clin Pharmacokinet. 1987; 12(2):123-35.
PMID: 2435442
DOI: 10.2165/00003088-198712020-00003.
[Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].
Kiesewetter H, Jung F, Blume J, Bulling B, Franke R
Klin Wochenschr. 1986; 64(1):29-37.
PMID: 2419635
DOI: 10.1007/BF01721578.
Studies on the kinetics and renal excretion of low and high molecular weight dextrans in preterm babies, newborns and young infants.
Emmrich P, Baumann W, Stechele U
Eur J Pediatr. 1977; 125(3):181-90.
PMID: 885145
DOI: 10.1007/BF00480595.
Antithrombotic drugs: part II.
Gallus A, Hirsh J
Drugs. 1976; 12(2):132-57.
PMID: 786606
DOI: 10.2165/00003495-197612020-00002.
Elimination of hexamethylene diisocyanate cross-linked polypeptides in patients with normal or impaired renal function.
Kohler H, Kirch W, Fuchs P, Stalder K, Distler A
Eur J Clin Pharmacol. 1978; 14(6):405-12.
PMID: 738348
DOI: 10.1007/BF00716381.
Effect of dextran on blood volume and interactions with volume regulatory systems.
HALDEMANN G, SCHAER H, Spring C, Frey P, Gebauer U, HOSSLI G
Intensive Care Med. 1979; 5(1):11-4.
PMID: 438421
DOI: 10.1007/BF01738996.
